Vida is selected to participate in NIH CAP Program
Vida’s President Lisa McElaney and I just returned from the first meeting of this year’s Commercialization Assistance Program (CAP) sponsored by the National Institutes of Health. The NIH CAP, now in its sixth year, is designed to assist NIH SBIR Phase II awardees transition their SBIR-developed technologies into the marketplace. Vida is one of about [...]
